Pfizer Inc
NYSE:PFE
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Realty Income Corp
NYSE:O
|
Real Estate
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
|
US |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
25.26
37.01
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
Abbvie Inc
NYSE:ABBV
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Realty Income Corp
NYSE:O
|
US | |
Walt Disney Co
NYSE:DIS
|
US | |
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Intrinsic Value
Pfizer Inc. is a research-based global biopharmaceutical company. [ Read More ]
The intrinsic value of one PFE stock under the Base Case scenario is hidden USD. Compared to the current market price of 28.85 USD, Pfizer Inc is hidden .
Valuation Backtest
Pfizer Inc
Run backtest to discover the historical profit from buying and selling PFE based on its intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Pfizer Inc
Current Assets | 37.8B |
Cash & Short-Term Investments | 7.1B |
Receivables | 15.1B |
Other Current Assets | 15.6B |
Non-Current Assets | 178.4B |
Long-Term Investments | 11.1B |
PP&E | 19B |
Intangibles | 129.7B |
Other Non-Current Assets | 18.6B |
Current Liabilities | 43.8B |
Accounts Payable | 5.1B |
Accrued Liabilities | 2.6B |
Short-Term Debt | 8.2B |
Other Current Liabilities | 27.9B |
Non-Current Liabilities | 84.7B |
Long-Term Debt | 57.5B |
Other Non-Current Liabilities | 27.2B |
Earnings Waterfall
Pfizer Inc
Revenue
|
55.6B
USD
|
Cost of Revenue
|
-16B
USD
|
Gross Profit
|
39.7B
USD
|
Operating Expenses
|
-28.9B
USD
|
Operating Income
|
10.8B
USD
|
Other Expenses
|
-13.4B
USD
|
Net Income
|
-2.6B
USD
|
Free Cash Flow Analysis
Pfizer Inc
USD | |
Free Cash Flow | USD |
Pfizer reported a strong Q2 2024 with $13.3 billion in revenue, marking a 14% growth excluding COVID products. Key drivers included Seagen acquisitions and products like NURTEC and Eliquis, offsetting declines in Xeljanz and IBRANCE. The adjusted gross margin improved to 79% from 76% last year. Pfizer raised its full-year revenue guidance by $1 billion to $59.5-$62.5 billion and adjusted EPS by $0.30 to $2.45-$2.65, forecasting COVID product revenues at $8.5 billion. They continue to focus on efficiencies, expecting $1.5 billion savings by 2027 from their Manufacturing Optimization Program.
What is Earnings Call?
PFE Profitability Score
Profitability Due Diligence
Pfizer Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.
Score
Pfizer Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.
PFE Solvency Score
Solvency Due Diligence
Pfizer Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.
Score
Pfizer Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
PFE Price Targets Summary
Pfizer Inc
According to Wall Street analysts, the average 1-year price target for PFE is 33.2 USD with a low forecast of 27.27 USD and a high forecast of 47.25 USD.
Shareholder Yield
Current shareholder yield for PFE is hidden .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
PFE Price
Pfizer Inc
Average Annual Return | 18.03% |
Standard Deviation of Annual Returns | 29.36% |
Max Drawdown | -57% |
Market Capitalization | 163.5B USD |
Shares Outstanding | 5 697 000 000 |
Percentage of Shares Shorted | 0.98% |
Ownership
PFE Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Pfizer Inc. is a research-based global biopharmaceutical company. The company is headquartered in New York City, New York and currently employs 79,000 full-time employees. The firm is engaged in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products. Its global portfolio includes medicines and vaccines. The firm offers therapeutic candidates in gastroenterology, dermatology, and cardiology, including etrasimod, an oral, selective sphingosine 1-phosphate (S1P) receptor modulator in development for a range of immuno-inflammatory diseases, including ulcerative colitis, Crohn’s Disease, atopic dermatitis, eosinophilic esophagitis, and alopecia areata. The firm works across markets to develop wellness, prevention, treatments and cures. The company collaborates with healthcare providers, governments and local communities to support and provide access to healthcare. The firm's medicines and vaccines provide value for healthcare providers and patients, through treatment of diseases, improvements in health, wellness.
Contact
IPO
Employees
Officers
The intrinsic value of one PFE stock under the Base Case scenario is hidden USD.
Compared to the current market price of 28.85 USD, Pfizer Inc is hidden .